There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

Int J Gynecol Cancer. 2022 Apr 4;32(4):578. doi: 10.1136/ijgc-2022-003348.

Richard Schwameis^{1

2}, Luis Chiva³, Philipp Harter⁴

¹ Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany richard.schwameis@meduniwien.ac.at.
² Division of General Gynecology and Gynecologic Oncology, Department of Obstetrics and Gynecology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
³ Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Madrid, Spain.
⁴ Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.

No abstract available

Keywords: cystadenocarcinoma; cytoreduction surgical procedures; general surgery; operative; ovarian cancer; serous; surgical procedures.

MeSH terms